3 Reasons To Own IMAX Shares For The Long Term

In what he described as a “draconian view,” MKM Partners analyst Eric Handler reiterated a Buy rating on Imax Corp (USA) IMAX and cut its price target from $40 to $30.

The $30 price target still reflects a 41-percent upside from the low-$21 range IMAX shares were trading at intra-day Thursday.

“We recognize investors have grown tired of overly optimistic sellside global box office projections and more often than not of late, downward estimate revisions,” said Handler in a note (see his track record here). The stock is at its lowest level since December 2012.

Related Benzinga Pro Headline: 3G Filing Shows Primecap Mgmt Reporting 8.29% Stake In IMAX

Conservative Revisions

The analyst cut his estimated 2017 global box office sales by 18 percent to $959 million, about flat year over year.

He also assumed no increase in average revenue per screen in 2018 and is not considering any savings from the company’s $20 million cost cutting plan.

The result of which is a 2017 revenue estimate reduced from $424 million to $373 million and adjusted EBITDA down from $136 million to $100 million. Both of which went from above consensus to below.

Estimates for 2018 were likely slashed, down to $415 million in sales and $128 million adjusted EPS down from $451 million and $162 million respectively.

“In our view, this outlook should hopefully prove conservative given what appears to be a stronger film slate for IMAX screens,” said Handler.

Long-Term Growth Is Still Possible

Despite these significant downward revisions, the company still warrants a Buy rating because of three drivers:

    1. IMAX has the potential to more than double its core theater network over the next 10 years.
    2. The company also has a strong first-mover advantage when it comes to new, out-of-home virtual reality centers, which is coupled with strategic exhibition partners.
    3. IMAX can continue to leverage the optionality from content partnerships to its advantage.

Besides long-term development strategies, IMAX benefits from its strong balance sheet. The company currently has $190 million in cash and no noteworthy debt, which will allow for its second $200 million share buyback.

Related Links:

Analyst Gives IMAX Two Thumbs Down On Weak Q2 Box Office

Movie Theater Stocks Tumble Following Bearish Comments From A Credit Suisse Analyst

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorLong IdeasPrice TargetReiterationAnalyst RatingsTechMediaTrading IdeasEric HandlerMKM Partners
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!